In this scenario, and considering that, to our knowledge, no data are available on the effects of a combined treatment with adiponectin and CSF derived from MS patients (MS-CSF), the aim of the present study was to investigate the possible interring mechanism of adiponectin against MS-CSF toxicity. The gene discussed is ADIPOQ; the disease is myeloid sarcoma.